This inventor holds 5 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Dupont Nutrition Biosciences Aps, Universite Laval (Canada), International N&h Denmark Aps. Active years: 2006-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Notre-Dame-du-Bon-Conseil, CA (2006)
- Québec, CA (2013)
- Quebec, CA (2022 - 2023)
Company Filing History:
2 out of 149 
2 out of 2 
1 out of 30 
Years Active: 2006-2025
Title: Sylvain Moineau: Innovator in Bacteriophage Resistance and Gene Editing
Introduction
Sylvain Moineau is a prominent inventor based in Québec, Canada. He has made significant contributions to the fields of microbiology and genetic engineering. With a total of 5 patents, his work focuses on enhancing the capabilities of lactic acid bacteria and advancing gene editing technologies.
Latest Patents
One of his latest patents is titled "Lactic acid bacterium with a reduction of sensitivity to cos-type bacteriophages." This invention relates to a specific strain of lactic acid bacteria that exhibits reduced sensitivity to cos-type bacteriophages. The patent also outlines methods for engineering these bacteria for use in milk fermentation. Another notable patent is "Anti-CRISPR polynucleotides and polypeptides and methods of use." This patent provides methods and compositions for utilizing anti-CRISPR proteins in plants, which includes modulating Cas endonuclease activity and improving the frequency of homologous recombination.
Career Highlights
Throughout his career, Sylvain Moineau has worked with notable organizations such as DuPont Nutrition Biosciences Aps and Université Laval in Canada. His research has significantly impacted the understanding and application of bacteriophage resistance in lactic acid bacteria.
Collaborations
He has collaborated with esteemed colleagues, including Christophe Fremaux and Philippe Horvath. Their joint efforts have further advanced the research in the fields of microbiology and genetic engineering.
Conclusion
Sylvain Moineau's innovative work in bacteriophage resistance and gene editing continues to influence the scientific community. His patents reflect a commitment to advancing technology in microbiology and genetics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile